STEPHEN M. KANOVSKY - 07 May 2025 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Director
Signature
/s/ Ali Olivo, Attorney-in-Fact
Issuer symbol
NEO
Transactions as of
07 May 2025
Net transactions value
+$31,124
Form type
4
Filing time
09 May 2025, 17:24:53 UTC
Previous filing
13 Aug 2024
Next filing
03 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KANOVSKY STEPHEN M Director 9490 NEOGENOMICS WAY, FORT MYERS /s/ Ali Olivo, Attorney-in-Fact 09 May 2025 0001713090

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Purchase $31,124 +4,000 +11% $7.78 40,090 07 May 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 4,269 07 May 2025 Common Stock 4,269 $22.52 Direct
holding NEO Stock Option (Right to Buy) 3,448 07 May 2025 Common Stock 3,448 $28.54 Direct
holding NEO Stock Option (Right to Buy) 3,714 07 May 2025 Common Stock 3,714 $40.90 Direct
holding NEO Stock Option (Right to Buy) 13,882 07 May 2025 Common Stock 13,882 $8.10 Direct
holding NEO Stock Option (Right to Buy) 8,353 07 May 2025 Common Stock 8,353 $14.82 Direct
holding NEO Stock Option (Right to Buy) 8,672 07 May 2025 Common Stock 8,672 $13.71 Direct
holding NEO Restricted Stock Unit 12,254 07 May 2025 Common Stock 12,254 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Once vested, the shares of common stock are not subject to expiration.